Catherine Skari
-
Jul- 2025 -22 JulyNews
SICKLE CELL DISEASE | Intranasal Fentanyl Shows Promise for Rapid Pain Relief in Adults
Fentanyl is a powerful painkiller that has already been widely used in children with SCD and in adults with cancer…
Read More » -
21 JulyTIF News
EMPOWERING NURSING PRACTICE IN HAEMOGLOBINOPATHIES | Discover the New TIF Guide
Nurses are the heart of haemoglobinopathy care. Their role spans far beyond routine tasks—encompassing complex clinical duties, patient advocacy, case…
Read More » -
16 JulyNews
YOUR RIGHTS, YOUR VOICE | The New Edition of TIF’s Essential Patient Guide is Here!
The Thalassaemia International Federation (TIF) is delighted to announce the publication of the 2nd edition of its guide “Know Your…
Read More » -
11 July
-
8 JulyScientific Literature
The Impact of Various Types of Α-Thalassemia οn Perinatal Complications and Pregnancy Outcomes in Pregnant Women
Abstract This study aims to investigate the adverse effects of different types of α-thalassemia on pregnant women and their differences,…
Read More » -
2 JulyScientific Literature
Transfusion Strategies in Thalassemia and Sickle Cell Disease SITE-SIMTI-SIdEM Good Practice
Abstract This document is the tool through which the knowledge developed by biomedical research is transferred to daily clinical practice.…
Read More » -
Jun- 2025 -25 JuneTIF News
ITD2025 OFFICIAL REPORT | Uniting Communities, Prioritising Patients
This year’s campaign, led by the Thalassaemia International Federation (TIF) and its 242 member-organisations across 67 countries, was guided…
Read More » -
20 JuneScientific News
WHO Issues First Global Guideline on Sickle Cell Disease in Pregnancy
Why This Matters High maternal risk: Pregnant women with SCD face a 4–11× greater risk of maternal mortality and…
Read More » -
15 JuneNews
EMPOWERING THE AMERICAS | Secure Your Spot at the 1st TIF Pan-American Conference & 2nd RAIN Summit
Visit the Conference Page for further information.
Read More » -
5 June


